Work disability rates in RA. Results from an inception cohort with 24 years follow-up

Rheumatology

Volumn 51, Issue 2, 2012, Pages 385-392

  Nikiphorou, Elena ^a   Guh, Daphne ^b   Bansback, Nick ^b,c   Zhang, Wei ^b,c   Dixey, Josh ^d   Williams, Peter ^e   Young, Adam ^a  

^a St Albans City Hospital   (United Kingdom)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NEW CROSS HOSPITAL   (United Kingdom)

^e MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

Rheumatoid arthritis; Work disability

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE DURATION; EMPLOYMENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYMPTOM; UNITED KINGDOM; WORK DISABILITY;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; COHORT STUDIES; COMORBIDITY; DISABILITY EVALUATION; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84862907509     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker401     Document Type: Article

References (39)

1. Sokka T, Kautiainen H, Pincus T et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 2010;12:R42.
2. Burton W, Morrison A, Maclean R et al. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med 2006;56:18-27.
3. Black C. Working for a healthier tomorrow. http://www.dwp.gov.uk/docs/hwwb-working-for-a-healthiertomorrow.pdf (31 March 2011, date last accessed).
4. Barrett EM, Scott DGI, Wiles JN et al. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology 2000;39:1403-9.
5. Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002;61: 335-40.
6. Puolakka K, Kautiainen H, Mottonen T et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. Arthritis Rheum 2004;50:55-62.
7. Van den Hout WB, Goekoop-Ruiterman YPM, Allaart CF et al. Additional costs of initial therapy including infliximab (IFX) in patients with early rheumatoid arthritis (RA) may be compensated by the value of sustained working hours: 2 year results of the BeSt study. Arthritis Rheum 2006; 54(suppl.):S227-8.
8. Bejarano V, Quinn M, Conaghan PG et al. Adalimumab plus methotrexate improves work stability and reduces job loss in early rheumatoid arthritis (RA): results of the prevention of work disability (PROWD) study. Arthritis Rheum 2006;54(suppl.):4037-8.
9. Young A, Dixey J, Cox N et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology 2000;39: 603-11.
10. Van der Heijde DMPM, van't Hof MA, van Riel PLCM et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
11. Young A, Wilkinson P, Talamo J et al. Socio-economic factors in the presentation and outcome of early rheumatoid arthritis Lessons for the health service? Ann Rheum Dis 2000;59:794-9.
12. Young A, Koduri G. Extra articular manifestations and complications of RA. Best Prac Res Clin Rheumatol 2007; 21:907-27.
13. Arnett FC, Edworthy SM, Bloch DA et al. The ARA 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond 1992;26:76-82.
15. James D, Young A, Kulinskaya E et al. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology 2004;43: 369-76.
16. Pintilie M. Competing Risks: a Practical Perspective. West Sussex: John Wiley & Sons, 2006.
17. Satagopan JM, Ben-Porat L, Berwick M et al. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-35.
18. Albers JM, Kuper HH, van Riel PL et al. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology 1999;38:423-30.
19. Lacaille D, Sheps S, Spinelli JJ et al. Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 2004;51:843-52.
20. Wolfe F, Allaire S, Michaud K. The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 2007;34:2211-7.
21. Eberhardt K, Larsson BM, Nived K et al. Work disability in rheumatoid arthritis - development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007;34:481-7.
22. Sokka T, Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001;28:1718-22.
23. Jäntti J, Aho K, Kaarela K et al. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatol 1999;38:1138-41.
24. Kaarela K, Lehtinen K, Luukainen R. Work capacity of patients with inflammatory joint disease. Scand J Rheumatol 1987;16:403-6.
25. Sokka T, Kautiainen H, Mottonen T et al. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999;26:1681-5.
26. Kenny GP, Yardley JE, Martineau L et al. Physical work capacity in older adults: implications for the aging worker. Am J Ind Med 2008;51:610-25.
27. Yelin E, Meenan R, Nevitt M. Work disability in rheumatoid arthritis: effects of disease, social and work factors. Ann Intern Med 1980;92:551-6.
28. Pincus T, Mitchell JM, Burkhauser RV. Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: comparisons with rheumatoid arthritis. J Clin Epidemiol 1989;42:449-57.
29. Doeglas D, Suurmeijer T, Krol B et al. Work disability in early rheumatoid arthritis. Ann Rheum Dis 1995;54: 455-60.
30. Mau W, Bornmann M, Weber H et al. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol 1996;35:652-9.
31. de Croon EM, Sluiter JK, Nijssen TF et al. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2004;63:1362-7.
32. Allaire S, Wolfe F, Niu J et al. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. Arthritis Rheum 2008;59:1082-9.
33. Wolfe F, Haley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17.
34. Rheumatoid arthritis: the management of rheumatoid arthritis in adults. National Institute of Health and Clinical Excellence. February 2009. http://www.nice.org.uk/Guidance/CG79 (31 March 2011, date last accessed).
35. Kiely PDW, Brown AK, Edwards CJ et al. Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. Rheumatology 2009;48:765-72.
36. Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69: 631-7.
37. Puolakka K, Kautiainen H, Mottonen T et al. Impact of initial aggressive drug treatment with a combination of disease-modifying anti-rheumatic drugs on the development of work disability in early rheumatoid arthritis. A five-year randomized follow up trial. Arthritis Rheum 2004; 50:55-62.
38. Puolakka K, Kautiainen H, Mottonen T et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41.
39. Grigor C, Capell H, Stirking A et al. Effect of a treatment strategy of tight control of rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.